long half-life and large variability [Regulatives / Guidelines]

posted by martin  – Austria, 2020-07-29 14:57 (211 d 22:09 ago) – Posting: # 21798
Views: 1,811

Dear all,

I would appreciate the forum members thoughts on the following situation.

In short:My interpretation of regulatoy guidelines: adding additional fixed effect factors to the factors mentioned in the guidelines is typically considered as not acceptable by regulators.

best regards & looking forward to some ideas to potentially address this situation

martin

Complete thread:

Activity
 Admin contact
21,356 posts in 4,458 threads, 1,493 registered users;
online 7 (0 registered, 7 guests [including 3 identified bots]).
Forum time: Friday 13:07 UTC (Europe/Vienna)

Those who make no mistakes are making the biggest mistakes of all 
they are attempting nothing new.    Anthony de Mello

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5